tirzepatide judge Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute GLP-1 Saga Continues: FDA Ends

PloS One (2012) 7:e37236

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL 0.25 mg and 0/5 mg, 1.5 mL Pen 0.25 mg 0.5 mg NDC 0169-4132-12List 413212 OZEMPIC (semaglutide) injection For Single Patient Use Only 2 mg/1.5 mL (1.34 mg/mL) Prefilled pen Pen delivers doses in 0.25 mg or 0.5 mg increments only For subcutaneous use only Use OZEMPIC once weekly Contains: 1 OZEMPIC pen, 6 NovoFine Plus 32G needles, Product Literature

Being on the 503A Bulks List is a supply chain permission

Before discontinuing its use, it's essential to recognize withdrawal symptoms

However, these side effects typically remain mild and often diminish over time